High‐risk and intermediate‐high–risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution-Reference-Cited by-同舟云学术

High‐risk and intermediate‐high–risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution

Published:2020-04-27 Issue:8 Volume:128 Page:563-569
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathol

Author:

Jug Rachel¹^ORCID,Foo Wen‐Chi¹^ORCID,Jones Claudia¹,Ahmadi Sara²,Jiang Xiaoyin “Sara”¹^ORCID

Affiliation:

1. Department of Pathology Duke University Medical Center Durham North Carolina

2. Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22283

Reference22 articles.

1. Evaluation of a Thyroid Nodule

2. The Natural History of Benign Thyroid Nodules

3. GROSS AND MICROSCOPIC FINDINGS IN CLINICALLY NORMAL THYROID GLANDS*

4. American Association of ClinicalEndocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules: Executive Summary of Recommendations

5. The 2017 Bethesda System for Reporting Thyroid Cytopathology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy;Thyroid®;2024-08-07

2. Monitoring Outcomes of Indeterminate Thyroid Nodules and Predictive Capabilities of Molecular Testing;Annals of Otology, Rhinology & Laryngology;2024-07-29

3. The negative outlook: Long‐term follow up of ThyroSeq negative and low‐risk nodules;Cancer Cytopathology;2024-06-20

4. Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules: a meta-analysis;Endocrine Connections;2024-05-21

5. ThyroSeq overview on indeterminate thyroid nodules: An institutional experience;Diagnostic Cytopathology;2024-03-30